September 19, 2023 | Vensana Capital® Portfolio News

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A